Jacobs Levy Equity Management
ZYME icon

Jacobs Levy Equity Management’s Zymeworks ZYME Stock Holding History

Jacobs Levy Equity Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
+42,786
New +$1.01M ﹤0.01% 692
2025
Q2 		– Sell
-12,040
Closed -$143K – 1188
2025
Q1 		$143K Sell
12,040
-344,128
-97% -$4.69M ﹤0.01% 1038
2024
Q4 		$5.21M Sell
356,168
-166,472
-32% -$2.33M 0.02% 424
2024
Q3 		$6.56M Sell
522,640
-129,088
-20% -$1.41M 0.03% 393
2024
Q2 		$5.55M Sell
651,728
-64,754
-9% -$576K 0.02% 440
2024
Q1 		$7.54M Buy
716,482
+348,441
+95% +$3.87M 0.03% 348
2023
Q4 		$3.82M Buy
368,041
+304,040
+475% +$2.42M 0.02% 483
2023
Q3 		$406K Sell
64,001
-115,895
-64% -$856K ﹤0.01% 838
2023
Q2 		$1.55M Buy
+179,896
New +$1.61M 0.01% 617

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jacobs Levy Equity Management's ZYME Position: Q1 2026 in Review

Jacobs Levy Equity Management opened a new position in Zymeworks (ZYME) in Q1 2026: 42,786 shares worth $1.07M. The stake represents ﹤0.01% of the portfolio and ranks #692 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in ZYME as recently as Q1 2025.

Jacobs Levy Equity Management first reported a position in ZYME in Q2 2023 and has held it in 9 quarters since. The position peaked at $7.54M in Q1 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Jacobs Levy Equity Management held 42,786 shares of Zymeworks worth $1.07M as of Q1 2026.
  • Zymeworks was a new Jacobs Levy Equity Management position in Q1 2026.
  • Zymeworks made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #692 holding.
  • Jacobs Levy Equity Management first reported a position in Zymeworks in Q2 2023 and has held it in 9 quarters since.
  • Jacobs Levy Equity Management's Zymeworks position peaked at $7.54M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.